$140K to advance Alzheimer’s detection in diverse populations
The research focuses on evaluating the effectiveness of the blood test for a specific biomarker of the disease.
Journey to expand Native Hawaiian Place of Learning begins for cohort
The inaugural cohort has engaged in culturally-based activities such as moʻokūʻauhau, mālama ʻāina and oli.
Smoking’s impact across racial, ethnic groups focus of UH study
UH Cancer Center researchers explore smoking habits, epigenetics, and lung cancer risk.
Hawai?i benefits from UH 惭ā苍辞补 being a national leader in federal health funding
麻豆传媒惭ā苍辞补 received $57.8 million in 2023, placing at 130 out of 2,886 other entities that received NIH funding.
New renderings preview UH Cancer Center’s clinical trials research hub
New renderings of the first floor and images of the pharmacy lab on the second floor were recently released.
National Cancer Institute highlights UH research
The studies focused on pancreatic ductal adenocarcinoma and prostate cancer shed light on associated novel biomarkers.
New blood biomarkers linked to Alzheimer’s
Alzheimer’s disease is projected to affect an estimated 152.8 million individuals by 2050.
Dementia risk factors differ among ethnicities
Approximately 23% of Alzheimer’s and related dementia cases in individuals aged 65 and older can be linked to controllable risk factors.
Lab to lifesaver: UH research powers medical breakthroughs
The FDA panel announced a breakthrough and approved the use of eflornithine in adult and pediatric patients with neuroblastoma.
Link between STI and advanced prostate cancer debunked
Most studies investigating the potential association of trichomoniasis involved only White populations.